Strategy

Mike Tremblay November 5, 2019

This is another article in my continuing commentary on market access and politics. The focus in this case is to look more closely at behaviours of people involved from government, industry and healthcare. Occupying these roles are people who bring their own psychological perspective to how they apply their knowledge and skills to their work. […]

Mike Tremblay October 8, 2019

This article is a continuation of my commentary on the politics of healthcare with particular focus on issues that likely interest those involved in market access and government relations. In this case, I’m commenting on government and market failure in healthcare. A future article will present what I call a ‘reform pathway’ laying out some […]

Mike Tremblay July 6, 2019

To some extent Academic Health Science Centres [AHSCs] are caught between the research push and market pull. If they prioritise technology transfer, they opt for a research push approach that emphasises the availability of technologies or innovations for market-based actors based on potential commercial application. While the university mission within an AHSC will emphasise the […]

Mike Tremblay July 4, 2019

It is not unreasonable to have concerns about the cost of medicines. Drug costs are usually influenced by government policies on pricing and reimbursement of medicines themselves. These range from simple discount seeking to more complex approaches such as conditional approvals, and value-based pricing (perhaps a subject for another posting). These can achieve a measure […]

Mike Tremblay July 3, 2019

Discussions on health literacy are increasing as healthcare providers, clinicians, payers and patients consider what this means for healthcare. Having been involved in launching the world’s first digital interactive health channel in the UK in 2000, one thing I learned is not to assume that everyone is alike or has common interests. Healthcare systems are […]

Mike Tremblay June 23, 2019

Andrew Yang is a democrat contender for president of the United States. He has expressed concern about a ‘jobless future’ as Martin Ford puts it [Rise of the Robots: Technology and the Threat of a Jobless Future], from technological change, in particular changes coming from the application of artificial intelligence in the workplace, which may […]

Mike Tremblay March 6, 2019

The relevance of value in establishing the positioning of medicines is the new normal for pharmaceutical marketing. Pharmaceutical companies have customers who are highly constrained by whether healthcare system funding is sustainable long term. Remember, payers think epidemiologically and in multiple years of costed care so industry needs to assess how that can be understood […]

Mike Tremblay January 15, 2019

The AI agenda is for me all about augmenting human reasoning; what I call cognology (cognitive focus) to distinguish from technology (physical focus). This is the core challenge to work flow and adoption. Here are some thoughts on the application of John Boyd’s OODA decision making from military decision making to healthcare decision making. Boyd […]